相似文献
1
Non-specific leucocyte migration inhibition of gynaecological carcinoma patients.
Clin Exp Immunol. 1979 Nov;38(2):356-60.
2
[Studies on tumor-specific immune response evaluated by leucocyte migration inhibition test under agarose-plate in gynecological malignancy (author's transl)].
Acta Obstet Gynaecol Jpn. 1981 Jul;33(7):1015-24.
3
[The utilisation of the leukocyte migration inhibition test (L.M.T) in carcinoma of cervix uteri (author's transl)].
Arch Geschwulstforsch. 1980;50(2):169-72.
4
[Leukocyte migration inhibition in women with tumors in an environment with ovarian carcinoma antigen and encephalitogenic factor].
Cas Lek Cesk. 1984 Mar 23;123(12):354-7.
5
[Suppression of leukocyte migration by autologous and allogeneic tumor extracts in kidney cancer patients].
Vopr Onkol. 1978;24(12):50-5.
6
[Inhibition of leucocyte migration in women with ovarian carcinoma, and its dependence on the quantity of lymphocytes forming E-rosettes (author's transl)].
Cas Lek Cesk. 1981 Sep 24;120(38):1150-4.
7
Inhibition of leukocyte migration in agar by soluble extract from a human ovarian carcinoma cell line.
Jpn J Exp Med. 1982 Jun;52(3):119-24.
8
Leucocyte migration inhibition test in patients with gynaecologic malignancy.
Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove. 1981;24(4):415-89.
9
A sequential study of humoral factors in ovarian neoplasms.
Indian J Pathol Microbiol. 1994 Jul;37(3):319-26.
10
Formalinized tumour cells in the leucocyte migration inhibition test.
Clin Exp Immunol. 1975 Oct;22(1):126-32.
本文引用的文献
1
Human lymphocyte migration as a parameter of hypersensitivity.
Acta Med Scand. 1967 Feb;181(2):247-56. doi: 10.1111/j.0954-6820.1967.tb07255.x.
2
Cellular immunity as a host response to squamous carcinoma of the cervix.
Am J Obstet Gynecol. 1971 Nov;111(6):751-5. doi: 10.1016/0002-9378(71)90484-4.
3
Antibody cytotoxicity studies in ovarian and cervical malignancies.
Obstet Gynecol. 1973 Nov;42(5):644-50.
4
Tumor-specific antigens and reexpression of fetal antigens in mammalian cells.
Prog Exp Tumor Res. 1974;19:45-58. doi: 10.1159/000395848.
5
Cell-mediated immunity in patients with ovarian carcinoma.
Am J Obstet Gynecol. 1973 Feb 15;115(4):467-70. doi: 10.1016/0002-9378(73)90392-x.
6
In vitro lymphocyte stimulation by a soluble antigen from malignant melanoma.
N Engl J Med. 1970 Aug 13;283(7):329-33. doi: 10.1056/NEJM197008132830702.
7
An immunologic comparison between serous cystadenocarcinoma of the ovary and other human gynecologic tumors.
Am J Obstet Gynecol. 1973 Nov 15;117(6):849-53. doi: 10.1016/0002-9378(73)90501-2.
8
Quantitation of antigens in normal and malignant ovarian tissue.
Am J Obstet Gynecol. 1975 Oct 1;123(3):302-4. doi: 10.1016/0002-9378(75)90203-3.
9
Cellular hypersensitivity in patients with squamous cell carcinoma of the cervix.
Am J Obstet Gynecol. 1975 Jan 1;121(1):91-5. doi: 10.1016/0002-9378(75)90981-3.
10
Circulatory and cellular immune responses to squamous cell carcinoma of the uterine cervix.
Am J Obstet Gynecol. 1976 Sep 1;126(1):116-21. doi: 10.1016/0002-9378(76)90475-0.
Zotero 插件